Protara Therapeutics (TARA)
(Delayed Data from NSDQ)
$3.19 USD
-0.02 (-0.62%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.18 -0.01 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Protara Therapeutics, Inc. has a market cap of $123.85M, which represents its share price of $3.21 multiplied by its outstanding shares number of 38.58M. As a small-cap company, TARA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TARA 3.19 -0.02(-0.62%)
Will TARA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TARA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TARA
Protara Therapeutics (TARA) Moves to Buy: Rationale Behind the Upgrade
TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy
TARA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TARA
Is TARA ready to move higher? 20 Day Moving Average Support shows up after sliding 0.62%
Analysts Predict Up to 840% Jump for These 2 ‘Strong Buy’ Penny Stocks
Crossed Above 20 Day Moving Average appears for TARA after 5.94% move
Stochastic Reached Oversold appears for TARA after 1.3% move
Citizens JMP healthcare analysts hold an analyst/industry conference call